BMRN
Conviction 53HealthcareScan · Thu, Sep 24, 2026Biomarin Pharmaceutical Inc (BMRN) closed at $61.37 (-1.36%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 37, RS Rating 73, -12.6% from its 52-week high, +3.2% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upJul 24 – Jul 272 scans
- Breaking out nowJul 281 scan
- Broke outJul 291 scan
- Setting upAug 201 scan
Recent news
- BioMarin Pharmaceutical stock holds at $63.94 as analysts stay bullishAD HOC NEWS · Wed, Sep 23, 2026
- BioMarin Pharmaceutical stock holds near its 52-week lowAD HOC NEWS · Tue, Sep 22, 2026
- BioMarin: Why I See Significant Upside Into 2027 (NASDAQ:BMRN)Seeking Alpha · Mon, Sep 21, 2026
- BioMarin Pharmaceutical Inc. (BMRN): Stock Analysis Reveals 43% Potential UpsideDirectorsTalk Interviews · Mon, Sep 21, 2026
- BioMarin Pharmaceutical stock holds near a $12.38 billion valueAD HOC NEWS · Sun, Sep 20, 2026
- BMRN Q2 2026 Earnings: EPS Beats Estimates by 4.05% While Shares Slip 1.75% - Earnings Outlook Updatecareplusvn.com · Sun, Sep 20, 2026
Congress activity
Disclosed STOCK Act trades in BMRN
Insider activity
SEC Form 4 transactions in BMRN
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Plenge Robert M Director · Common Stock · 2026-09-10 | Grant | 6.14K | — | 2026-09-10 | 2026-09-14 |
Dere Willard H Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
ANDERSON ELIZABETH M Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Ho Maykin Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Walbert Timothy P Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
CLARK IAN T Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Countouriotis Athena Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Walbert Timothy P Director · Common Stock · 2026-06-02 | Other | — | — | 2026-06-02 | 2026-06-04 |
Enyedy Mark J Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
Bodem Barbara W. Director · Common Stock · 2026-06-02 | Grant | 7.49K | $0 | 2026-06-02 | 2026-06-04 |
SEC filings
EDGAR filings in BMRN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.